Matterhorn Biosciences
M-TCR cell therapies targeting a new hallmark of cancer
7 employees · est. 2020 · Basel, Switzerland
TC BioPharm
Treating cancer with γδ T cells | Nasdaq Ticker - $TCBP
51 employees · est. 2014 · United Kingdom
TC BioPharm is the older company (2020 vs 2014); TC BioPharm is the larger of the two.
Side-by-Side Comparison
| Metric | Matterhorn Biosciences | TC BioPharm |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2014 older |
| Headquarters | ||
| Headquarters | Basel, Switzerland | United Kingdom |
| Employees | ||
| Employees | 7 | 51 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series Unknown | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $30.00M | $46.61M |
| Funding Rounds | ||
| Funding Rounds | 1 | 9 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Cell Therapy, Cancer Treatment, MR1-directed Therapy, T Cell Receptors, Cancer-Specific Metabolites, Immunotherapy, M-TCR Platform, Oncology, Cancer Immunology, Cellular Therapies, Biopharmaceuticals | Cell Therapy, CAR-T Therapy, Cancer Treatment, Gamma Delta T Cells, Clinical-Stage, Allogeneic Therapy, Immunotherapy, Regenerative Medicine, Clinical Development, Solid Tumors, Infectious Disease, Biopharmaceuticals, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Melanoma |
| Website | ||
| Website | matterhornbiosciences.com | tcbiopharm.com |
About Matterhorn Biosciences
Matterhorn Biosciences, established in 2020, is pioneering a breakthrough in the biopharmaceutical sector with its focus on MR1 directed cell therapy. Positioned as a leader, the company leverages its proprietary M-TCR cell therapy platform to target the underlying mechanisms of cancer. Operating o...
About TC BioPharm
TC BioPharm (Ticker: $TCBP) is a publicly traded, clinical-stage cell therapy company that was founded in 2013. The company is at the forefront of developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as pioneering gamma delta T cell therapies for the treatm...
We will tell you when either one moves
BounceWatch watches Matterhorn Biosciences and TC BioPharm for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Matterhorn Biosciences and TC BioPharm — by email.
Frequently Asked Questions
Compare Matterhorn Biosciences with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Matterhorn Biosciences on 29 Mar 2026, and TC BioPharm on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
